The reason that the detection of these mutations is important is that it can be used as a target therapy for gene mutations, for example, EGFR-inhibitor for KRAS wildtype CRC and immune checkpoint inhibitors for MSI-high solid tumor [8]. The gene discussed is EGFR; the disease is colorectal carcinoma.